Results 211 to 220 of about 260,266 (297)
P-129 Addressing the gaps: evaluating an innovative 24/7 community nursing model for children at end of life [PDF]
Tracie Lewin-Taylor +4 more
openalex +1 more source
This review summarizes artificial intelligence (AI)‐supported nonpharmacological interventions for adults with chronic rheumatic diseases, detailing their components, purpose, and current evidence base. We searched Embase, PubMed, Cochrane, and Scopus databases for studies describing AI‐supported interventions for adults with chronic rheumatic diseases.
Nirali Shah +5 more
wiley +1 more source
Objective In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently, and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of the trajectory of a ...
Ji Soo Kim +18 more
wiley +1 more source
Assessing Community Readiness to Use Social Platforms for Stroke Survivors' Recovery and Caregiver Support in Saudi Arabia. [PDF]
Babkair LA +6 more
europepmc +1 more source
An Attempt to Assess the Impact of AI as a Modern Tool for Regional Policy in the Process of Innovative and Economic Development of European Regions [PDF]
Nikolay Tsonkov, Miroslav Zlatev
openalex +1 more source
Objective Australian evidence on lived and care experiences of chronic musculoskeletal shoulder pain (CMSP), irrespective of disorder classification or disease, is limited. However, such evidence is important for person‐centered care and informing local service pathways and care guidelines or standards.
Sonia Ranelli +8 more
wiley +1 more source
Investigating Elderly Individuals' Acceptance of Artificial Intelligence (AI)-Powered Companion Robots: The Influence of Individual Characteristics. [PDF]
Liu J, Wang X, Zhang J.
europepmc +1 more source
Hydroxychloroquine Associated With Lower Glomerular Filtration Rate Decline in Lupus Nephritis
Objective Hydroxychloroquine (HCQ) protects kidney function in lupus nephritis (LN) by preventing flares, yet some cohort studies show no significant benefit in kidney function with HCQ. Clarifying these conflicting findings by showing early and long‐term benefits of HCQ on kidney function preservation is critical.
Shivani Garg +9 more
wiley +1 more source

